Clinical Trial

Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry

Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done in order to assess the cardiovascular events known as cardiovascular toxicity of chemotherapy agents and radiotherapy protocols in cancer subjects to identify risk prediction, prevention and treatment of cancer therapy-related cardiovascular toxicity and cancer therapy-related cardiac dysfunction
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-10-11; most recent amendment 2025-06-16.
Status change: Not Yet Recruiting → Recruiting 2025-06-16
Trial Details
NCT Number NCT06086132
Lead Sponsor University of Bologna
Collaborators: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Conditions Cancer Related Cardiovascular Toxicity
Enrollment 10,000 participants
Start Date 2025-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-19